FORMULARY DESIGNATION OF CIMETIDINE AS THE PRIMARY INTRAVENOUS HISTAMINE-H2-RECEPTOR ANTAGONIST

被引：3

作者：

BERKOWITZ, HS ^{[1
]}

机构：

[1] OWEN HEALTHCARE INC,NASSAU CTY MED CTR,E MEADOW,NY 11554

来源：

AMERICAN JOURNAL OF HOSPITAL PHARMACY | 1992年 / 49卷 / 01期

关键词：

D O I：

10.1093/ajhp/49.1.134

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：134 / 135

页数：2

共 20 条

[1]

ALGOZZINE GJ, 1989, AM J HOSP PHARM, V46, P1183

[2] GASTRIC-ULCER HEALING WITH RANITIDINE AND CIMETIDINE - A MULTICENTER STUDY [J].

BARON, JH ;

PERRIN, VL .

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1983, 18 (07) :973-976

[3]

BAUMAN J, 1991, P T, V16, P127

[4] PREVENTION OF DUODENAL-ULCER OCCURRENCE - DOUBLE-BLIND COMPARISON OF RANITIDINE AND CIMETIDINE [J].

BOLIN, TD ;

DAVIS, AE ;

BILLINGTON, B .

JOURNAL OF CLINICAL GASTROENTEROLOGY, 1987, 9 (03) :310-313

[5]

FELDMAN M, 1990, NEW ENGL J MED, V323, P1749

[6]

FELDMAN M, 1990, NEW ENGL J MED, V323, P1672

[7] DRUGS 5 YEARS LATER - CIMETIDINE .2. ADVERSE REACTIONS AND PATTERNS OF USE [J].

FRESTON, JW .

ANNALS OF INTERNAL MEDICINE, 1982, 97 (05) :728-734

[8]

HANSTEN PD, 1990, DICP ANN PHARMAC, V24, P38

[9]

KELLOW JE, 1983, DIGESTION, V27, P105, DOI 10.1159/000198938

[10] INTERACTIONS AND NON-INTERACTIONS WITH RANITIDINE [J].

KIRCH, W ;

HOENSCH, H ;

JANISCH, HD .

CLINICAL PHARMACOKINETICS, 1984, 9 (06) :493-510

← 1 2 →